News & Press Releases
Filter by:
PBMs Enter New Era of Legal Scrutiny
February 10, 2026
Law360 Healthcare Authority featured insights from Member Theresa Carnegie in an article focused on the Consolidated Appropriations Act of 2026 which introduces new regulations for pharmacy benefit managers, particularly aimed at fee and cost transparency.
Competition Policy International featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan.
Mintz has further enhanced its high-powered litigation practice with a five-partner team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan.
The FDA Ad Crackdown Has Pharma's Attention. But Companies Aren't 'Radically Changing Course'—Yet
February 9, 2026
Joanne Hawana was quoted by Endpoints News in an article about how the pharma industry continues to spend hundreds of millions of dollars on ads despite a significant FDA crackdown on misleading consumer ads.
Reuters featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan.
Cadwalader Litigation Co-leaders Head to Mintz in 5-Partner Move
February 9, 2026
The American Lawyer featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan. The article highlights the team’s focus on high-stakes disputes, including representing major corporations in antitrust opt-out cases, and explains why Mintz was the right fit.
